IL4 and COVID-19: Studies have shown that severe COVID-19 is accompanied by hypercytokinemia with high levels of pro-inflammatory cytokines such as IL-6 and IL-1β as well as anti-inflammatory cytokines such as IL-4 and IL-10 [12,14,41].